NEOPRAN, created in 1961 (Switzerland), from 126 sister brands and 279 competing brands. The NEOPRAN brand is owned by GALENICA AG, a company listed in Zurich. The ISIN, the company's International Securities Identification Number, is CH0360674466. The sector of NEOPRAN is Medical Distribution.
Investment simulator :
Portfolio valuation
GALENICA AG
(NEOPRAN)
over 5 years*
CHF 97.33